Sponsored Research
Pamela S. Douglas of Cardiology has received an award from the North Shore University Hospital for a project entitled "MITRAL Trial." Total funding will be $153,176.
Pamela S. Douglas of Cardiology has received an award from the General Hospital Corporation (Mass) for a project entitled "Heart Flow 01 Study." Total funding will be $76,464.
Gillian D. Schmidler of Cardiology has received an award from the Patient-Centered Outcomes Research Institute for a project entitled "Topic Refinement 2015." Total funding will be $19,567.
Pierluigi Tricoci of Cardiology has received a sub-award (2R01-HL102482-05A1) through Thomas Jefferson University for a project entitled "Variation in Human Platelet Function: PAR4 Functional Genomics." Total funding will be $21,319.
Andrew J. Muir of Gastroenterology has received a sub-award (U01-DK082867-08) through the University of North Carolina - Chapel Hill for a project entitled "HBV Clinical Research Network Site Application Subcontract to UNC." Total funding will be $89,054.
Rodger A. Liddle of Gastroenterology has received an award from TaiwanJ Pharmaceuticals Co. Ltd for a project entitled "Pancreatitis and Pancreatic fibrosis." Total funding will be $32,640.
Anna Barton (Mentor: William Yancy) of General Internal Medicine has received an award from the Diabetes Action Research and Education Foundation for a project entitled "Examining the Use and Effectiveness of a Very Low-Carbohydrate Diet in Type 1 Diabetes." Total funding will be $10,000.
Rowena J. Dolor of General Internal Medicine has received a sub-award (5P30-HS021639-03) through Oregon Health & Science University for a project entitled "Meta-Network Learning and Research Center (Meta-LARC)." Total funding will be $9,100.
Kenneth E. Schmader of Geriatrics has received an award from the American Federation for Aging Research for a project entitled "Hartford COE in Geriatric Medicine and Geriatric Psychiatry Sustainability Fund." Total funding will be $10,000.
Keith M. Sullivan of Hematological Malignancies and Cellular Therapy has received a sub-award (U01-HL128566-) through Emory University for a project entitled "Marrow transplant compared to supportive care in adults with sickle cell disease." Total funding will be $17,733.
Anthony D. Sung of Hematological Malignancies and Cellular Therapy has received a sub-award (R01-HL124112-) through Memorial Sloan-Kettering Cancer Center for a project entitled "Microbiota-focused strategies to mitigate GVHD." Total funding will be $60,059.
Susanna Naggie of Infectious Diseases has received a sub-award (UM1-A1068636-) through Brigham and Women's Hospital for a project entitled "Randomized Trial to Prevent Vascular Events in HIV- REPRIEVE (A5332)."
Susanna Naggie of Infectious Diseases has received a sub-award (5UM1-AI068636-09) through Brigham and Women's Hospital for a project entitled "ACTG, Aids Clinical Trials Group." Total funding will be $9,823.
Daniel J. Sexton of Infectious Diseases has received an award (200-2011-42042 TO2) from the Centers for Disease Control and Prevention for a project entitled "Accelerating hospital reporting to NHSN's Antibiotic Use Option." Total funding will be $504,517.
Michael A. Hauser of Medical Genetics has received a sub-award (R01-EY22651-05) through the University of Chicago for a project entitled "Mexican American Glaucoma Genetic Study (MAGGS)." Total funding will be $135,750.
Kimberly L. Blackwell of Medical Oncology has received an award from the Susan G. Komen Breast Cancer Foundation for a project entitled "Examining the Role of Cholesterol Metabolites on the Estrogen Receptor Signaling Pathway." Total funding will be $200,000.
Herbert I. Hurwitz of Medical Oncology has received an award for a project entitled "Development of novel immunotherapies for patients with metastatic colorectal cancer." Total funding will be $400,000.
Richard F. Riedel of Medical Oncology has received an award from the Sarcoma Alliance for Research Through Collaboration for a project entitled "SARC 024: A blanket protocol to study oral regorafenib in patients with refractory liposarcoma, osteogenic sarcoma, and Ewing/Ewing-like sarcomas - Cohort A." Total funding will be $14,946.
Industry-sponsored Clinical Trials
Scott J. Denardo of Cardiology has received an award from AstraZeneca LP for a project entitled "Affordability and Real-world antiplatelet Treatment Effectiveness after Myocardial Infarction Study." Total funding will be $34,001.
Jason Koontz of Cardiology has received an award from Medtronic, Inc. for a project entitled "AdaptResponse." Total funding will be $104,284.
Robert J. Noveck of Cardiology has received an award from Drip Drop for a project entitled "Drip Drop Clinical Research Study." Total funding will be $30,000.
Manesh R. Patel of Cardiology has received an award from Medinol USA for a project entitled "NIR-TRAKS." Total funding will be $52,600.
Manesh R. Patel of Cardiology has received an award from MaQuet Cardiovascular for a project entitled "Maquet review of HF patients treated with IABP." Total funding will be $54,040.
Jonathan P. Piccini of Cardiology has received an award from Medtronic, Inc. for a project entitled "MICRA-CAS." Total funding will be $42,940.
Matthew T. Roe of Cardiology has received an award from AstraZeneca Pharmaceuticals, LP for a project entitled "Gout CV Outcomes." Total funding will be $125,567.
Pierluigi Tricoci of Cardiology has received an award from Amgen, Inc. for a project entitled "Efficacy and Safety of Romosozumab with Placebo in Men with Osteoporosis." Total funding will be $286,091.
Pierluigi Tricoci of Cardiology has received an award from Sanofi US for a project entitled "Adjudication of Clinical Events for Sanofi Protocol EFC14204." Total funding will be $305,705.
Eric Velazquez of Cardiology has received an award from Amgen, Inc. for a project entitled "DELD SET." Total funding will be $234,017.
Manal F. Abdelmalek of Gastroenterology has received an award from Gilead Sciences, Inc. for a project entitled "Gilead 384-1497 A Phase 2, Randomized, Open Label Study Evaluating the Safety, Tolerability, and Efficacy of GS-4997 alone or in Combination with Simtuzumab (SIM) in Subjects with Nonalcoholic Steatohepatitis (NASH) and Fibrosis Stages F2-F3." Total funding will be $82,034.
Andrew J. Muir of Gastroenterology has received an award from Gilead Sciences, Inc. for a project entitled "A Phase 3, Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Safety and Efficacy of Sofosbuvir/Velpatasvir/GS-9857 Fixed Dose Combination for 12 Weeks in Direc." Total funding will be $423,530.
Keith M. Sullivan of Hematological Malignancies and Cellular Therapy has received an award from GlaxoSmithKline for a project entitled "Phase II, randomised, observer-blind, placebo-controlled,multicentre study to assess the safety, immunogenicity and efficacy of GSK Bilologicals ' Herpes Zoster HZ/su candidate vaccine to adults aged 18 years and older with haematologic malignancies." Total funding will be $194,133.
Ara D. Metjian of Hematology has received an award from Daiichi Sankyo Inc for a project entitled "Edoxaban in VTE Associated with Cancer Hokusai VTE Cancer Study DU176b-D-U311." Total funding will be $38,965.
Susanna Naggie of Infectious Diseases has received an award from the Institute for Medical Research, Inc. for a project entitled "An Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with or without Ribavirin (RBV) in US Veterans with Genotype 1 Chronic Hepatitis C Virus (HCV) Infection (Topaz)." Total funding will be $31,431.
Susanna Naggie of Infectious Diseases has received an award from the Institute for Medical Research, Inc. for a project entitled "Randomized Open-label Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 and ABT-333 Co-administered with Ribavarin in Adults with Genotype 1 Chronic HCV Infection and HIV-1 Co-infection (Turquoise-1)." Total funding will be $31,431.
Herbert I. Hurwitz of Medical Oncology has received an award from Pharmacyclics, Inc. for a project entitled "A Multi center study of the Bruton's Tyrosine Kinase (BTK) inhibitor, Ibrutinib in combination with MEDI4736." Total funding will be $1,291,066.
Neal E. Ready of Medical Oncology has received an award from AstraZeneca LP for a project entitled "A Phase II, Randomized, Open-Label, Multi-Center, Global Study of MEDI4736 Monotherapy, Tremelimumab Monotherapy and MEDI4736 in Combination with Tremelimumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck SCCHN." Total funding will be $282,995.
John H. Strickler of Medical Oncology has received an award from MedImmune, Inc. for a project entitled "A phase I open label dose escalation and dose-expansion study to evaluate the safety toloerability pharmcokinetics immunogenicity and antitumor activate of Medi-9447 alone and in combination with MEDI." Total funding will be $425,759.
Laurie D. Snyder of Pulmonary, Allergy, and Critical Care Medicine has received an award from Gilead Sciences, Inc. for a project entitled "GS-US-218-1797." Total funding will be $41,966.
Momen Wahidi of Pulmonary, Allergy, and Critical Care Medicine has received an award from Premier Research for a project entitled "Remimazolam (CNS7056) Patients Undergoing Bronchoscopy." Total funding will be $93,370.